Department of Medicine, Hennepin Healthcare and University of Minnesota, 701 Park Avenue, Minneapolis, MN, 55415, USA.
Department of Medicine, Addiction Medicine Section, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, 97239-3098, Portland, OR, USA.
Addict Sci Clin Pract. 2024 Apr 11;19(1):29. doi: 10.1186/s13722-024-00455-9.
Hospitalizations involving opioid use disorder (OUD) are increasing. Medications for opioid use disorder (MOUD) reduce mortality and acute care utilization. Hospitalization is a reachable moment for initiating MOUD and arranging for ongoing MOUD engagement following hospital discharge. Despite existing quality metrics for MOUD initiation and engagement, few hospitals provide hospital based opioid treatment (HBOT). This protocol describes a cluster-randomized hybrid type-2 implementation study comparing low-intensity and high-intensity implementation support strategies to help community hospitals implement HBOT.
Four state implementation hubs with expertise in initiating HBOT programs will provide implementation support to 24 community hospitals (6 hospitals/hub) interested in starting HBOT. Community hospitals will be randomized to 24-months of either a low-intensity intervention (distribution of an HBOT best-practice manual, a lecture series based on the manual, referral to publicly available resources, and on-demand technical assistance) or a high-intensity intervention (the low-intensity intervention plus funding for a hospital HBOT champion and regular practice facilitation sessions with an expert hub). The primary efficacy outcome, adapted from the National Committee on Quality Assurance, is the proportion of patients engaged in MOUD 34-days following hospital discharge. Secondary and exploratory outcomes include acute care utilization, non-fatal overdose, death, MOUD engagement at various time points, hospital length of stay, and discharges against medical advice. Primary, secondary, and exploratory outcomes will be derived from state Medicaid data. Implementation outcomes, barriers, and facilitators are assessed via longitudinal surveys, qualitative interviews, practice facilitation contact logs, and HBOT sustainability metrics. We hypothesize that the proportion of patients receiving care at hospitals randomized to the high-intensity arm will have greater MOUD engagement following hospital discharge.
Initiation of MOUD during hospitalization improves MOUD engagement post hospitalization. Few studies, however, have tested different implementation strategies on HBOT uptake, outcome, and sustainability and only one to date has tested implementation of a specific type of HBOT (addiction consultation services). This cluster-randomized study comparing different intensities of HBOT implementation support will inform hospitals and policymakers in identifying effective strategies for promoting HBOT dissemination and adoption in community hospitals.
NCT04921787.
涉及阿片类药物使用障碍(OUD)的住院治疗正在增加。阿片类药物使用障碍(MOUD)的药物可降低死亡率和急性护理利用率。住院是开始 MOUD 和安排住院后继续 MOUD 参与的可达时刻。尽管存在 MOUD 启动和参与的质量指标,但很少有医院提供基于医院的阿片类药物治疗(HBOT)。本方案描述了一项集群随机混合 2 型实施研究,比较了低强度和高强度实施支持策略,以帮助社区医院实施 HBOT。
四个具有启动 HBOT 项目专业知识的州实施中心将为有兴趣启动 HBOT 的 24 家社区医院(每个中心 6 家医院)提供实施支持。社区医院将随机分配到 24 个月的低强度干预(分发 HBOT 最佳实践手册、基于手册的讲座系列、转介给公开可用资源和按需技术援助)或高强度干预(低强度干预加上为医院 HBOT 冠军提供资金和与专家中心定期进行实践促进会议)。主要疗效结局改编自国家质量保证委员会,是出院后 34 天接受 MOUD 的患者比例。次要和探索性结局包括急性护理利用、非致命性过量、死亡、MOUD 在不同时间点的参与、医院住院时间和反对医疗建议的出院。主要、次要和探索性结局将从州医疗补助数据中得出。通过纵向调查、定性访谈、实践促进接触日志和 HBOT 可持续性指标评估实施结果、障碍和促进因素。我们假设随机分配到高强度臂的患者接受治疗的比例将在出院后接受更多的 MOUD 治疗。
在住院期间开始 MOUD 可改善出院后的 MOUD 参与度。然而,很少有研究测试不同的实施策略对 HBOT 的采用、结果和可持续性的影响,迄今为止只有一项研究测试了特定类型的 HBOT(成瘾咨询服务)的实施。这项比较不同 HBOT 实施支持强度的集群随机研究将为医院和政策制定者提供信息,以确定促进社区医院 HBOT 传播和采用的有效策略。
NCT04921787。